Sökning: WFRF:(Wei Yongyue) >
SIPA1L3 methylation...
-
Zhang, RuyangHarvard University,Nanjing Medical University
(författare)
SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival : an epigenomic–smoking interaction analysis
- Artikel/kapitelEngelska2019
Förlag, utgivningsår, omfång ...
-
2019-04-17
-
Wiley,2019
-
14 s.
Nummerbeteckningar
-
LIBRIS-ID:oai:lup.lub.lu.se:59013cac-2605-442a-9444-0e8e84953b83
-
https://lup.lub.lu.se/record/59013cac-2605-442a-9444-0e8e84953b83URI
-
https://doi.org/10.1002/1878-0261.12482DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:art swepub-publicationtype
-
Ämneskategori:ref swepub-contenttype
Anmärkningar
-
Smoking cessation prolongs survival and decreases mortality of patients with non-small-cell lung cancer (NSCLC). In addition, epigenetic alterations of some genes are associated with survival. However, potential interactions between smoking cessation and epigenetics have not been assessed. Here, we conducted an epigenome-wide interaction analysis between DNA methylation and smoking cessation on NSCLC survival. We used a two-stage study design to identify DNA methylation–smoking cessation interactions that affect overall survival for early-stage NSCLC. The discovery phase contained NSCLC patients from Harvard, Spain, Norway, and Sweden. A histology-stratified Cox proportional hazards model adjusted for age, sex, clinical stage, and study center was used to test DNA methylation–smoking cessation interaction terms. Interactions with false discovery rate-q ≤ 0.05 were further confirmed in a validation phase using The Cancer Genome Atlas database. Histology-specific interactions were identified by stratification analysis in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) patients. We identified one CpG probe (cg02268510 SIPA 1L3 ) that significantly and exclusively modified the effect of smoking cessation on survival in LUAD patients [hazard ratio (HR) interaction = 1.12; 95% confidence interval (CI): 1.07–1.16; P = 4.30 × 10 –7 ]. Further, the effect of smoking cessation on early-stage LUAD survival varied across patients with different methylation levels of cg02268510 SIPA 1L3 . Smoking cessation only benefited LUAD patients with low methylation (HR = 0.53; 95% CI: 0.34–0.82; P = 4.61 × 10 –3 ) rather than medium or high methylation (HR = 1.21; 95% CI: 0.86–1.70; P = 0.266) of cg02268510 SIPA 1L3 . Moreover, there was an antagonistic interaction between elevated methylation of cg02268510 SIPA 1L3 and smoking cessation (HR interaction = 2.1835; 95% CI: 1.27–3.74; P = 4.46 × 10 −3 ). In summary, smoking cessation benefited survival of LUAD patients with low methylation at cg02268510 SIPA 1L3 . The results have implications for not only smoking cessation after diagnosis, but also possible methylation-specific drug targeting.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Lai, LinjingNanjing Medical University
(författare)
-
Dong, XuesiNanjing Medical University,Southeast University
(författare)
-
He, JieyuNanjing Medical University
(författare)
-
You, DongfangNanjing Medical University
(författare)
-
Chen, ChaoNanjing Medical University
(författare)
-
Lin, LijuanNanjing Medical University
(författare)
-
Zhu, YingNanjing Medical University
(författare)
-
Huang, HuiNanjing Medical University
(författare)
-
Shen, SipengNanjing Medical University,Harvard University
(författare)
-
Wei, LiangminNanjing Medical University
(författare)
-
Chen, XinNanjing Medical University
(författare)
-
Guo, YichenHarvard University
(författare)
-
Liu, LiyaNingbo University
(författare)
-
Su, LiNanjing Medical University,Harvard University
(författare)
-
Shafer, AndreaMassachusetts General Hospital,Harvard University
(författare)
-
Moran, SebastianUniversity of Barcelona
(författare)
-
Fleischer, ThomasOslo university hospital
(författare)
-
Bjaanæs, Maria MoksnesOslo university hospital
(författare)
-
Karlsson, AnnaLund University,Lunds universitet,Create Health,Annan verksamhet, LTH,Lunds Tekniska Högskola,Forskningsgrupp Lungcancer,Forskargrupper vid Lunds universitet,Other operations, LTH,Faculty of Engineering, LTH,Research Group Lung Cancer,Lund University Research Groups(Swepub:lu)med-akn
(författare)
-
Planck, MariaLund University,Lunds universitet,Create Health,Annan verksamhet, LTH,Lunds Tekniska Högskola,Forskningsgrupp Lungcancer,Forskargrupper vid Lunds universitet,Other operations, LTH,Faculty of Engineering, LTH,Research Group Lung Cancer,Lund University Research Groups(Swepub:lu)onk-mpl
(författare)
-
Staaf, JohanLund University,Lunds universitet,Create Health,Annan verksamhet, LTH,Lunds Tekniska Högskola,Forskningsgrupp Lungcancer,Forskargrupper vid Lunds universitet,Other operations, LTH,Faculty of Engineering, LTH,Research Group Lung Cancer,Lund University Research Groups(Swepub:lu)onk-jst
(författare)
-
Helland, ÅslaugOslo university hospital,University of Oslo
(författare)
-
Esteller, ManelUniversity of Barcelona
(författare)
-
Wei, YongyueNanjing Medical University,Harvard University
(författare)
-
Chen, FengNanjing Medical University
(författare)
-
Christiani, David C.Massachusetts General Hospital,Nanjing Medical University,Harvard University
(författare)
-
Harvard UniversityNanjing Medical University
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Molecular Oncology: Wiley13:5, s. 1235-12481574-78911878-0261
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Zhang, Ruyang
-
Lai, Linjing
-
Dong, Xuesi
-
He, Jieyu
-
You, Dongfang
-
Chen, Chao
-
visa fler...
-
Lin, Lijuan
-
Zhu, Ying
-
Huang, Hui
-
Shen, Sipeng
-
Wei, Liangmin
-
Chen, Xin
-
Guo, Yichen
-
Liu, Liya
-
Su, Li
-
Shafer, Andrea
-
Moran, Sebastian
-
Fleischer, Thoma ...
-
Bjaanæs, Maria M ...
-
Karlsson, Anna
-
Planck, Maria
-
Staaf, Johan
-
Helland, Åslaug
-
Esteller, Manel
-
Wei, Yongyue
-
Chen, Feng
-
Christiani, Davi ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
Molecular Oncolo ...
- Av lärosätet
-
Lunds universitet